T1	Participants 71 125	sedation of autistic patients during dental treatment.
T2	Participants 233 275	autistic patients during dental treatment.
T3	Participants 475 509	13 subjects aged 5.8 to 14.7 years
T4	Participants 573 597	patients taking the drug
T5	Participants 1523 1561	autistic patients for dental treatment
